BlackRock Japan’s Ultragenyx Pharmaceutical RARE Stock Holding History

BlackRock Japan’s Portfolio RARE Stock Details RARE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$29K	Sell	417 -11	-3%	-$780	﹤0.01%	1068
2016 Q3	$30K	Hold	428	–	–	﹤0.01%	1057
2016 Q2	$21K	Sell	428 -1	-0.2%	-$65	﹤0.01%	1155
2016 Q1	$27K	Sell	429 -94	-18%	-$6.15K	﹤0.01%	1142
2015 Q4	$59K	Sell	523 -22	-4%	-$2.2K	﹤0.01%	998
2015 Q3	$52K	Buy	545 +48	+10%	+$5.5K	﹤0.01%	970
2015 Q2	$51K	Buy	+497	New	+$38.6K	﹤0.01%	1077
2014 Q3	–	Sell	-550	Closed	-$25K	–	1295
2014 Q2	$25K	Sell	550 -1,103	-67%	-$45.4K	﹤0.01%	1131
2014 Q1	$81K	Buy	+1,653	New	+$85.1K	﹤0.01%	1096

Other funds holding RARE

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

CWAM

Columbia Wanger Asset Management Chicago, Illinois $6.69B AUM 31.14% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

BlackRock Japan's RARE Position: Q4 2016 in Review

BlackRock Japan reduced its Ultragenyx Pharmaceutical (RARE) stake by 2.6% in Q4 2016, selling an estimated $780 and leaving 417 shares worth $29K. The position accounts for ﹤0.01% of the portfolio, ranked #1068.

BlackRock Japan first reported a position in RARE in Q1 2014 and has held it in 9 quarters since. The position peaked at $81K in Q1 2014. 175 funds tracked by Wall St. Rank hold RARE as of Q4 2016.

BlackRock Japan held 417 shares of Ultragenyx Pharmaceutical worth $29K as of Q4 2016.
BlackRock Japan sold 11 Ultragenyx Pharmaceutical shares in Q4 2016, an estimated $780.
Ultragenyx Pharmaceutical made up ﹤0.01% of BlackRock Japan's portfolio in Q4 2016, its #1068 holding.
BlackRock Japan first reported a position in Ultragenyx Pharmaceutical in Q1 2014 and has held it in 9 quarters since.
BlackRock Japan's Ultragenyx Pharmaceutical position peaked at $81K in Q1 2014.
175 funds tracked by Wall St. Rank held Ultragenyx Pharmaceutical as of Q4 2016.

Based on BlackRock Japan's 13F filing for Q4 2016, filed 10 Feb 2017.